Management of Diabetes in 2023: Updates and Future Directions​

The novel diabetes drugs can seem like an alphabet soup with exciting new mechanisms and innovations. At our next Medicine Grand Rounds, Sarah Kim will demystify the latest diabetes management drugs and explore the current state and future of continuous glucose monitoring devices. From the latest advances in the management of both type 1 and type 2, this talk will be a comprehensive and clinically relevant update in the field.

Speaker
Sarah Kim, MD is professor of Medicine and clinician-educator in the Division of Endocrinology and Metabolism at UCSF Health and ZSFG. Boarded in adult endocrinology as well as general pediatrics, her clinic work has focused on adult diabetes and adult and pediatric obesity. Sarah directs the UCSF Diabetes Teaching Center where she focuses on diabetes educational programs and serves as a co-investigator on diabetes research studies.

Note: Closed captions will be available within 48-72 hours after posting.

Program

Bob Wachter: Introduction
00:01:35-00:56:53 – Management of Diabetes in 2023: Updates and Future Directions​ with Sarah Kim, professor of Medicine and clinician-educator in the Division of Endocrinology and Metabolism at UCSF Health and ZSFG
00:56:55-01:02:26 – Q and A

See previous Medical Grand Rounds:
• September 21: The Inaugural Hollander Rounds: Clinical Problem Solving with Brad Sharpe
   • The Inaugural Hollander Rounds: Clinical P...  
• September 14: Loneliness and Social Isolation Among Older Adults: The Role of Clinicians
   • Loneliness and Social Isolation Among Olde...  
• September 7: Summer Covid-19 Update
   • Summer Covid-19 Update  
• June 29: The Final Covid-19 Grand Rounds: What Have We Learned?    • The Final Covid-19 Grand Rounds: What Have...  
• June 22: A Fireside Chat with Lindsey Criswell, Director of NIAMS    • A Fireside Chat with Lindsey Criswell, Dir...  

See all UCSF Covid-19 grand rounds, which have been viewed over 3M times, at    • UCSF Department of Medicine Medical Grand ...  .